Vagelos P Roy - Dec 16, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/** P. Roy Vagelos
Stock symbol
REGN
Transactions as of
Dec 16, 2021
Transactions value $
-$80,008
Form type
4
Date filed
12/20/2021, 03:13 PM
Previous filing
Dec 10, 2021
Next filing
Mar 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities -$12.1K -19 -0.86% $634.70 2.2K Dec 16, 2021 By 401(k) Plan
transaction REGN Common Stock Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities -$67.9K -107 -4.86% $635.03 2.1K Dec 16, 2021 By 401(k) Plan F1
holding REGN Common Stock 319K Dec 16, 2021 Direct
holding REGN Common Stock 142K Dec 16, 2021 by CLAT
holding REGN Common Stock 37.7K Dec 16, 2021 by Spouse as Trustee
holding REGN Common Stock 3.61K Dec 16, 2021 by trust for grandch F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 107 shares of Company stock on December 16, 2021 at prices ranging from $635.00 to $635.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 16, 2021 at each separate price.
F2 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.